99 related articles for article (PubMed ID: 12649665)
1. Mesonephric remnants or hyperplasia can cause abnormal pap smears: a study of three cases.
Welsh T; Fu YS; Chan J; Brundage HA; Rutgers JL
Int J Gynecol Pathol; 2003 Apr; 22(2):121-6. PubMed ID: 12649665
[TBL] [Abstract][Full Text] [Related]
2. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases.
Ferry JA; Scully RE
Am J Surg Pathol; 1990 Dec; 14(12):1100-11. PubMed ID: 2252101
[TBL] [Abstract][Full Text] [Related]
3. Mesonephric hyperplasia of the uterine cervix: a clinicopathologic study of 51 cases.
Seidman JD; Tavassoli FA
Int J Gynecol Pathol; 1995 Oct; 14(4):293-9. PubMed ID: 8598330
[TBL] [Abstract][Full Text] [Related]
4. Immunopathological study of mesonephric lesions of cervix uteri and vagina.
Kondi-Pafitis A; Kairi E; Kontogianni KI; Dimopoulou C; Sikiotis K; Smyrniotis V
Eur J Gynaecol Oncol; 2003; 24(2):154-6. PubMed ID: 12701967
[TBL] [Abstract][Full Text] [Related]
5. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
6. Mesonephric hyperplasia can cause abnormal cervical smears: report of three cases with review of literature.
Hejmadi RK; Gearty JC; Waddell C; Ganesan R
Cytopathology; 2005 Oct; 16(5):240-3. PubMed ID: 16181310
[TBL] [Abstract][Full Text] [Related]
7. Florid mesonephric hyperplasia of the cervix: a report of a case with review of the literature.
Ayroud Y; Gelfand MM; Ferenczy A
Int J Gynecol Pathol; 1985; 4(3):245-54. PubMed ID: 2414240
[TBL] [Abstract][Full Text] [Related]
8. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
9. Mesonephric remnant hyperplasia of the cervix: a clinicopathologic analysis of 14 cases.
Jones MA; Andrews J; Tarraza HM
Gynecol Oncol; 1993 Apr; 49(1):41-7. PubMed ID: 8482559
[TBL] [Abstract][Full Text] [Related]
10. Cervical mesonephric hyperplasia lacks KRAS/NRAS mutations.
Mirkovic J; Schoolmeester JK; Campbell F; Miron A; Nucci MR; Howitt BE
Histopathology; 2017 Dec; 71(6):1003-1005. PubMed ID: 28703285
[No Abstract] [Full Text] [Related]
11. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
Nassar A; Fleisher SR; Nasuti JF
Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675
[TBL] [Abstract][Full Text] [Related]
12. [Mesonephric hyperplasia in uterine cervix: report of two cases].
Zeng Y; Wu Y; Zhu X; Zhang S; Gu P; Zhu H; Qiu W; Yi X
Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):339-40. PubMed ID: 25030871
[No Abstract] [Full Text] [Related]
13. Urethral obstruction due to lobular mesonephric hyperplasia of the vagina--a case report.
Handoo A; Kini H; Pai R; Prabhu GG
Indian J Pathol Microbiol; 2005 Jan; 48(1):20-1. PubMed ID: 16758778
[TBL] [Abstract][Full Text] [Related]
14. Ductal-type mesonephric duct/remnant hyperplasia: distinguished from lobular or diffuse mesonephric hyperplasia by the presence of a myoepithelial cell layer and micropapillary tufting.
Roy SF; Wong J; Latour M; Reichetzer B; Rahimi K
Pathology; 2022 Apr; 54(3):378-381. PubMed ID: 34412858
[No Abstract] [Full Text] [Related]
15. The histogenetic origin of cervical mesonephric hyperplasia and mesonephric adenocarcinoma of the uterine cervix studied with immunohistochemical methods.
Lang G; Dallenbach-Hellweg G
Int J Gynecol Pathol; 1990; 9(2):145-57. PubMed ID: 1692008
[TBL] [Abstract][Full Text] [Related]
16. Cytologic findings in microglandular hyperplasia of the cervix.
Yahr LJ; Lee KR
Diagn Cytopathol; 1991; 7(3):248-51. PubMed ID: 1879260
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
[TBL] [Abstract][Full Text] [Related]
18. Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women.
Keating JT; Wang HH
Cancer; 2001 Apr; 93(2):100-5. PubMed ID: 11309774
[TBL] [Abstract][Full Text] [Related]
19. Mesonephric duct hyperplasia of the uterus. Report of two cases and three other cases of mesonephric duct remnant with findings of mucin histochemistry and lectin binding immunohistochemistry.
Inai K; Arihiro K; Tokuoka S; Katsube Y; Fujiwara A
Acta Pathol Jpn; 1989 Jul; 39(7):457-64. PubMed ID: 2801115
[TBL] [Abstract][Full Text] [Related]
20. Abnormal Pap smears, ASCUS still ob/gyn puzzle.
Titus K
JAMA; 1996 Oct; 276(13):1014-6. PubMed ID: 8847749
[No Abstract] [Full Text] [Related]
[Next] [New Search]
